Kayne Anderson Rudnick Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.17M | Sell |
11,847
-126
| -1% | -$44.9K | 0.01% | 274 |
|
|
2025
Q4 | $3.92M | Sell |
11,973
-490
| -4% | -$155K | 0.01% | 277 |
|
|
2025
Q3 | $3.52M | Buy |
12,463
+439
| +4% | +$127K | 0.01% | 284 |
|
|
2025
Q2 | $3.36M | Sell |
12,024
-5,454
| -31% | -$1.55M | 0.01% | 290 |
|
|
2025
Q1 | $5.45M | Sell |
17,478
-1,965
| -10% | -$580K | 0.01% | 266 |
|
|
2024
Q4 | $5.07M | Sell |
19,443
-3,422
| -15% | -$1.02M | 0.01% | 266 |
|
|
2024
Q3 | $7.37M | Sell |
22,865
-1,886
| -8% | -$617K | 0.02% | 254 |
|
|
2024
Q2 | $7.73M | Sell |
24,751
-3,113
| -11% | -$915K | 0.02% | 257 |
|
|
2024
Q1 | $7.92M | Sell |
27,864
-2,483
| -8% | -$727K | 0.02% | 263 |
|
|
2023
Q4 | $8.74M | Sell |
30,347
-1,848
| -6% | -$504K | 0.02% | 256 |
|
|
2023
Q3 | $8.65M | Sell |
32,195
-220
| -0.7% | -$54.9K | 0.02% | 257 |
|
|
2023
Q2 | $7.2M | Sell |
32,415
-11,592
| -26% | -$2.69M | 0.02% | 270 |
|
|
2023
Q1 | $10.6M | Buy |
44,007
+598
| +1% | +$147K | 0.03% | 244 |
|
|
2022
Q4 | $11.4M | Sell |
43,409
-3,478
| -7% | -$932K | 0.04% | 249 |
|
|
2022
Q3 | $10.6M | Buy |
46,887
+22,728
| +94% | +$5.51M | 0.04% | 241 |
|
|
2022
Q2 | $5.88M | Buy |
24,159
+156
| +0.6% | +$38.2K | 0.02% | 274 |
|
|
2022
Q1 | $5.8M | Buy |
24,003
+4,752
| +25% | +$1.09M | 0.02% | 270 |
|
|
2021
Q4 | $4.33M | Sell |
19,251
-1,409
| -7% | -$297K | 0.01% | 284 |
|
|
2021
Q3 | $4.39M | Sell |
20,660
-4,295
| -17% | -$989K | 0.01% | 276 |
|
|
2021
Q2 | $6.08M | Buy |
24,955
+1,005
| +4% | +$247K | 0.02% | 256 |
|
|
2021
Q1 | $5.96M | Buy |
23,950
+498
| +2% | +$119K | 0.02% | 245 |
|
|
2020
Q4 | $5.39M | Buy |
23,452
+1,919
| +9% | +$442K | 0.02% | 246 |
|
|
2020
Q3 | $5.47M | Sell |
21,533
-4,102
| -16% | -$1.02M | 0.02% | 238 |
|
|
2020
Q2 | $6.05M | Sell |
25,635
-5,212
| -17% | -$1.19M | 0.03% | 215 |
|
|
2020
Q1 | $6.25M | Sell |
30,847
-7,139
| -19% | -$1.56M | 0.04% | 203 |
|
|
2019
Q4 | $9.16M | Sell |
37,986
-944
| -2% | -$208K | 0.04% | 187 |
|
|
2019
Q3 | $7.53M | Sell |
38,930
-917
| -2% | -$176K | 0.04% | 192 |
|
|
2019
Q2 | $7.34M | Buy |
39,847
+667
| +2% | +$119K | 0.04% | 194 |
|
|
2019
Q1 | $7.44M | Sell |
39,180
-1,410
| -3% | -$269K | 0.04% | 179 |
|
|
2018
Q4 | $7.9M | Sell |
40,590
-482
| -1% | -$94K | 0.05% | 173 |
|
|
2018
Q3 | $8.52M | Sell |
41,072
-1,391
| -3% | -$274K | 0.05% | 177 |
|
|
2018
Q2 | $7.84M | Buy |
42,463
+741
| +2% | +$131K | 0.05% | 181 |
|
|
2018
Q1 | $7.11M | Buy |
41,722
+7,348
| +21% | +$1.35M | 0.05% | 182 |
|
|
2017
Q4 | $5.98M | Buy |
34,374
+694
| +2% | +$123K | 0.05% | 193 |
|
|
2017
Q3 | $6.28M | Buy |
33,680
+528
| +2% | +$93.6K | 0.06% | 188 |
|
|
2017
Q2 | $5.71M | Buy |
33,152
+2,044
| +7% | +$332K | 0.06% | 190 |
|
|
2017
Q1 | $5.1M | Buy |
31,108
+3,532
| +13% | +$587K | 0.06% | 196 |
|
|
2016
Q4 | $4.03M | Sell |
27,576
-120,885
| -81% | -$18.2M | 0.05% | 207 |
|
|
2016
Q3 | $24.8M | Buy |
148,461
+15,964
| +12% | +$2.7M | 0.31% | 92 |
|
|
2016
Q2 | $20.2M | Sell |
132,497
-1,688
| -1% | -$262K | 0.3% | 86 |
|
|
2016
Q1 | $20.1M | Sell |
134,185
-2,721
| -2% | -$404K | 0.33% | 85 |
|
|
2015
Q4 | $22.2M | Buy |
136,906
+3,504
| +3% | +$551K | 0.37% | 76 |
|
|
2015
Q3 | $18.5M | Sell |
133,402
-4,380
| -3% | -$690K | 0.31% | 82 |
|
|
2015
Q2 | $21.2M | Buy |
137,782
+22
| +0% | +$3.52K | 0.33% | 79 |
|
|
2015
Q1 | $22M | Buy |
137,760
+94,531
| +219% | +$14.9M | 0.34% | 81 |
|
|
2014
Q4 | $6.89M | Buy |
+43,229
| New | +$6.74M | 0.11% | 155 |
|
Other funds holding AMGN
VCM
VPM
Kayne Anderson Rudnick Investment Management's AMGN Position: Q1 2026 in Review
Kayne Anderson Rudnick Investment Management reduced its Amgen (AMGN) stake by 1.1% in Q1 2026, selling an estimated $44.9K and leaving 11,847 shares worth $4.17M. The position accounts for 0.01% of the portfolio, ranked #274.
Kayne Anderson Rudnick Investment Management first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $24.8M in Q3 2016. 3,135 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Kayne Anderson Rudnick Investment Management held 11,847 shares of Amgen worth $4.17M as of Q1 2026.
- Kayne Anderson Rudnick Investment Management sold 126 Amgen shares in Q1 2026, an estimated $44.9K.
- Amgen made up 0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #274 holding.
- Kayne Anderson Rudnick Investment Management first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
- Kayne Anderson Rudnick Investment Management's Amgen position peaked at $24.8M in Q3 2016.
- 3,135 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.